Lipocine
LPCN
LPCN
39 hedge funds and large institutions have $10.5M invested in Lipocine in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 0.61% → 0.71% (+0.1%)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Holders
39
Holding in Top 10
–
Calls
$1.11M
Puts
$143K
Top Buyers
| 1 | +$124K | |
| 2 | +$124K | |
| 3 | +$102K | |
| 4 |
VF
Virtu Financial
New York
|
+$86.3K |
| 5 |
Two Sigma Advisers
New York
|
+$53K |
Top Sellers
| 1 | -$337K | |
| 2 | -$193K | |
| 3 | -$31K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$26K |
| 5 |
Barclays
London,
United Kingdom
|
-$26K |